UW - Pulmonary Division - Fellowship Overview


		Transplant Service (All files listed below are in .pdf format and require Acrobat Reader) Syllabus -- UW NetID Required to Access These Files A randomized trial of inhaled cyclosporine in lung-transplant recipients. A review of lung transplant donor acceptability criteria. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Allograft rejection after lung transplantation. Assessment of survival benefit after lung transplantation by patient diagnosis. Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome. Bronchiolitis obliterans after human lung transplantation. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. Immunosuppressive Impact International Living Lung transplantation. Lung Lung Medical Non-heart-beating Noninfectious Paediatric lung transplanta Post-transplant Pulmonary Registry Risk The The Update in transplantation CF Cystic Cystic Fibrosis Since 1938.< Burkhloderia cepacia Risk Update in cystic fibrosis 2005. Use of COPD A Patients at high risk The ILD Clinical Effect Idiopathic Impact Lung Medical S The The clinical therapy after human lung transplantation. of secondary pulmonary hypertension on lung transplant outcome. guidelines for the selection of lung transplant candidates: 2006 update--A concensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. donor lung transplantation selection, technique, and outcome. transplantation opportunities for research and clinical advancement transplantation disease-specific considerations for referral complications of lung transplantation. donors in thoracic transplantation. pulmonary complications after lung transplantation. tion.pdf bronchiolitis obliterans. complications of solid organ and hematopoietic stem cell transplantation. of the International Society for Heart and Lung Transplantation: twenty-third official Adult Lung and Heart-Lung Transplantation Report--2006. quantification of early outcome after lung transplantation: donor, recipient, operative and post-transplant parameters. effect of primary graft dysfunction on survival after lung transplantation. predictive value of bronchiolitis obliterans syndrome stage O-p. 2005. fibrosis adult care: consensus conference report. br> > complex. Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation. > Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis. randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. of death after lung-volume-reduction-surgery. body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. advances in the diagnosis and therapy of the interstitial lung diseases. of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. pulmonary fibrosis: current trends in management. of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. transplantation for interstitial lung disease. treatment for pulmonary fibrosis: current trends, concepts and prospects. ix-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. course of patients with idiopathic pulmonary fibrosis. LAM The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. Pulmonary HTN Evaluation and management of the patient with pulmonary arterial hypertension. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. Pulmonary arterial hypertension. Treatment of pulmonary arterial hypertension.

		Pulmonary Medicine Home \| Fellowship Home \| UW Home \| UWMC \| DOM Home \| HMC \| FHCRC \| Academic Health Links \| Search SOM Please honor our copyrights and disclaimer. Copyright ©1998 University of Washington. All rights reserved. Comments to Donna Schier, dschier@u.washington.edu Last reviewed: November 16, 2006- Last updated: November 16, 2006